Kessler Judd S 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-01 12:57 pm Purchase |
2024-05-01 | 13D | Calidi Biotherapeutics, Inc. CLDI |
Kessler Judd S | 372,984 5.000% |
372,984 (New Position) |
Filing |